New data concerning treatment of urogenital cancer patients presented at annual congress of American Society of Clinical Oncology 2011
Journal Title: OncoReview - Year 2011, Vol 1, Issue 4
Abstract
INTRODUCTION: The annual congress of The American Society of Clinical Oncology took place between 03.06.2011 and 06.06.2011 in Chicago, the US.MATERIAL AND METHODS: Papers presented during ASCO are discussed in four sections: Testicular Cancer, Prostate Cancer, Kidney Cancer and Urothelial Carcinoma.RESULTS: About 160 original papers concerning urogenital cancers were surveyed. Phase III studies are discussed as well as the supplemental analyses of the phase III trials published during ASCO. A brief summary of phase I and phase II trials was also provided.Conclusion : The ASCO Annual Congress is the conclusion of the advances in the field of medical oncology.
Authors and Affiliations
Paweł Wiechno
Keywords
Related Articles
- EP ID EP53126
- DOI -
- Views 213
- Downloads 0
High risk pulmonary embolism in oncology
Pulmonary embolism is a frequent complication of both cancer and the oncologic therapy. There is still discussed the subject of optimal antithrombotic prophylaxis in oncology. This article presents the patient with metas...
Kontrola działań niepożądanych podczas terapii ewerolimusem – doświadczenia własne ośrodka
Założenia: Rak nerkowokomórkowy (RCC, renal cell carcinoma) stanowi 80–85% wszystkich nowotworów złośliwych nerki. Ewerolimus należy do grupy leków selektywnie hamujących kinazę mTOR, ostatnio został zarejestrowany do le...
Multiple myeloma. Practical aspects regarding diagnosis and treatment
Practical aspects of multiple myeloma diagnosis and treatment has been discussed. Myeloma diagnosis should be supported with immunoglobulin’s isotype and serum free light chain immunoglobulins studies. It is particularly...
Ewerolimus w codziennej praktyce klinicznej. Omówienie niemieckiego nieinterwencyjnego badania ewerolimusu w terapii przerzutowego raka nerki po niepowodzeniu leczenia inhibitorami kinaz tyrozynowych
Leczenie przerzutowego raka nerki ewerolimusem po niepowodzeniu terapii anty-VEGF jest obecnie standardem. Badacze niemieccy zebrali dane z 79 ośrodków w celu oceny bezpieczeństwa i skuteczności leku. Otrzymane wyniki by...
The quality of life and the sexual activity of prostate cancer patients after radical radiotherapy in comparison with group without cancer
[b]Background:[/b] Prostate cancer is a disease with a significant impact on quality of life (QoL) both during and after cancer treatment.[b]The aim of study[/b]: The aim of this study was assessment of QoL and sexual ac...